Cannabis Law Report

SEPTEMBER 21, 2022

Reiterates Adjusted EBITDA Profitability Run Rate by December 31, 2022. Reaffirms $150 to $170 Million in Annualized Cost Savings by December 31, 2022. Million in Q4 2022. 20, 2022 /PRNewswire/ – Aurora Cannabis Inc. (the of Aurora’s Q4 2022 consolidated net revenue 1 and 86.3%

Research and Development 52

Research and Development Cannabis Data Events 52

Veriheal

FEBRUARY 10, 2022

cloudPWR , a pioneer in cloud software for enterprise businesses and government agencies, is collaborating with fellow cloud-based solutions leader Accela to provide the South Dakota Department of Health (SDDOH) with an on-demand computer system-operated medical cannabis program registry. Med Card Registration via Cloud-based Registry.

Programs 52

Programs Chronic Pain Patients Conditions 52

Cannabis Law Report

AUGUST 16, 2022

August 16, 2022. The New York State Cannabis Control Board (“CCB”) approved 15 Adult-Use Conditional Processor (“AUCP”) licenses during its public meeting today, adding a key link in the state’s budding adult-use cannabis supply chain. The application window opened on June 28, 2022 and closes on August 31, 2022.

Supply Chain 52

Supply Chain Conditions Cannabinoids Programs 52

Canna Law Blog

SEPTEMBER 24, 2022

As part of New York Cannabis Control Board’s (CCB) meeting on August 15, 2022, the CCB proposed and approved John Kagia as the Office of Cannabis Management’s Director of Policy. First, the OCM clearly was looking for someone with a background in data analytics. A few interesting things to note based on the identified duties.

Policy 72

Policy Research and Development Data Legislation 72

Cannabis Law Report

JULY 11, 2022

The budget trailer bill eliminated the cannabis cultivation tax beginning July 1, 2022. The harvested cannabis was first sold or transferred by a cultivator to a distributor on or after July 1, 2022. The harvested cannabis was first sold or transferred by a cultivator to a distributor on or after July 1, 2022. View source.].

Cultivation 52

Cultivation Law Collective Retail 52

Cannabis Law Report

DECEMBER 21, 2021

Also in November, it reported positive data on its standout IND, CYB003. Headed by two-time entrepreneur of the year Kelsey Ramsden , one of Mind Cure’s primary focuses is its digital therapeutics program, iSTRYM. It’s also initiating phase 2a clinical trial into conditions such as eating disorders and fibromyalgia.

Clinical Trials 52

Clinical Trials Therapy Treatment DEA 52

Cannabis Law Report

APRIL 14, 2022

Accordingly, state pesticide programs have tried to provide some clarity to fill the gap left by EPA. pursuant to Drug Enforcement Agency (DEA) or state-level programs). Grow operations generate agricultural waste that must be managed and disposed of as a regulated or scheduled substance (e.g., million cars on the road.

Environment 52

Environment Agriculture Compliance Compliance 52

Cannabis Law Report

MAY 10, 2022

11 May 2022. First academic study of national medicinal cannabis data. Of the 248,000 scripts approved for Australians since inception of national medicinal cannabis scheme in 2016, many related to conditions for which the drug has limited evidence of efficacy, a new University of Sydney study shows.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Cannabis Law Report

DECEMBER 26, 2021

In furtherance of its program, the Company filed US Provisional Patent Application No. “Entheon is proud to be making significant strides in its Entheon IQ™ program,” says Timothy Ko, Chief Executive Officer of Entheon. US Provisional Patent Filed. ” In Vivo Toxicity Assays Completed.

Research and Development 52

Research and Development Clinical Trials Treatment Packaging 52

Cannabis Law Report

OCTOBER 22, 2021

Cybin’s Research and Development team has completed 74 in-vitro and in-vivo evaluations of Cybin’s expanding portfolio of psychedelic compounds being designed for potential therapeutic applications for several mental health conditions.

Research and Development 52

Research and Development Safety Media Data 52

Illinois News Joint

FEBRUARY 7, 2023

The Disparity and Availability Study’s purpose is to collect and analyze data and will report on whether discrimination exists in the Illinois cannabis industry. Illinois’ current cannabis licensing program does not consider race and gender for licensing. Constitution.

Agriculture 79

Agriculture Cannabis Policy Dispensary 79

Cannabis Law Report

MARCH 3, 2022

— Cannabis & Tech Today (@cannatechtoday) February 24, 2022. He also rejected requests to lift a federal ban on harm reduction policies like syringe exchange programs. I’ve worked on this for so long that I know not only can it work, sometimes it’s the only thing that works for some of these conditions.”. “We

Media 52

Media CBD Events THC 52

Cannabis Law Report

FEBRUARY 2, 2022

On January 25, 2022, the New York State Cannabis Control Board (CCB) held its fifth public meeting. During the meeting, Executive Director Chris Alexander announced the expansion of the medical cannabis program, including clinicians’ ability to certify patients for any clinical condition per their discretion.

Dispensary 52

Dispensary Retail Data Consumption 52

Cannabis Law Report

MARCH 8, 2022

DENVER) March 8, 2022 – Simplifya (“Simplifya” or “the Company”), the leading regulatory and operational compliance software platform serving the cannabis industry, announced the launch of its comprehensive suite of compliance solutions in New Mexico, expanding the company’s reach to 24 states.

Compliance 98

Compliance Compliance Research and Development Business 98

Cannabis Law Report

OCTOBER 26, 2021

Last week, the National Agricultural Statistics Service (NASS) began collecting data for its first ever Hemp Acreage and Production Survey. Yet, there is no comprehensive, national production data for it. 17, 2022, on the NASS website and in the NASS Quick Stats searchable database. That’s where NASS comes in. agriculture.

Hemp 52

Hemp Agriculture Data Collective 52

Cannabis Law Report

AUGUST 27, 2021

The Rules will be effective until at least August 19, 2022. New applicants may apply for either a conditional license or an annual license. Conditional license applications are prioritized over annual license applications to prioritize small business ownership. There are two types of fees: application fees and license fees.

Cultivation 105

Cultivation Conditions Business Cannabis 105

Veriheal

AUGUST 9, 2023

In contrast, a more significant proportion, 76%, recognized addiction as a medical condition, demonstrating increased understanding and compassion towards those facing such challenges. Equally, 76% believed that addiction is preventable and treatable, underscoring the value of early intervention and treatment programs.

Education 98

Education Vaping Cannabis Consumption 98

Cannabis Law Report

MAY 29, 2022

Fast Track review is for drugs that treat serious conditions and fill an unmet medical need. Furthermore, contracts with research organizations must be properly tailored to ensure appropriate human subject protection and data integrity. 12] DEA, Drug Scheduling, [link] (last visited May 13, 2022). [13] 1, 2022), [link]. [14]

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Freedom Leaf

OCTOBER 15, 2018

Frontier Data predicts total sales of all CBD products in the U.S. billion by 2022. Frontier Data predicts total sales of all CBD products in the U.S. billion by 2022. Legally, all CBD products in California must come through the regulated adult-use or medical programs. will top $1.9 John’s wort. will top $1.9

DEA 51

DEA CBD Pharmaceutical Epilepsy 51

Cannabis Law Report

JUNE 1, 2021

Remains on track to achieve positive Adjusted EBITDA during the second half of FY 2022. opportunities in Fiscal 2022.” ecosystem strategy continues to gain traction with focus to further capitalize on growth opportunities in the U.S. Fourth Quarter Fiscal 2021 Financial Summary. (in in millions of Canadian dollars, unaudited).

Data 95

Data Vaping Supply Chain Business 95

Cannabis Law Report

MAY 12, 2022

10 May 2022. The market has learned to adjust to less-than-ideal conditions while maintaining hope for progress in Washington. The shortcomings of social equity programs create risks for investors touting ESG principles, where good internal governance (or climate-friendly conduct) is lacking. Joseph Cioffi. Davis+Gilbert LLP.

Environment 52

Environment Banking Cannabis Data 52

Cannabis Law Report

JANUARY 20, 2022

Cumulatively, all of the 10-year agreements under Agrify’s TTK Solution program are currently projected to generate an estimated $850 million in total revenue. Agrify brings data, science, and technology to its customers for unparalleled control over cultivation and extraction. BILLERICA, Mass., About Agrify TTK Solution.

Extraction 52

Extraction Cultivation Hemp Data 52

Cannabis Law Report

AUGUST 17, 2021

Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced topline data from its open-label Phase 2 trial evaluating safety and efficacy of adjunctive oral ganaxolone treatment in 23 patients with seizures associated with tuberous sclerosis complex (TSC).

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

Cannabis Law Report

DECEMBER 16, 2021

Because recreational use of marijuana is increasing, especially as more states legalize it, the CDC believes it’s important for all workplaces to implement and address marijuana policies in their motor vehicle safety programs. This program gives New Mexico an edge in the growth of cannabis infrastructure.

Cannabinoids 52

Cannabinoids Retail Policy Cultivation 52

Cannabis Law Report

NOVEMBER 18, 2021

Fast Company’s new recognition program highlights technology breakthroughs that will define the future of their industries. The Winter 2021/2022 issue of Fast Company is available online now and will hit newsstands on Dec. The benefits of LED technology for greenhouses and vertical farms cannot be understated.

Wellness and Beauty 52

Wellness and Beauty Research and Development Food Environment 52

Cannabis Law Report

FEBRUARY 28, 2022

— MedMen to launch its global trademark licensing program beginning in Florida. The transaction is subject to customary closing conditions, including applicable regulatory approvals. first loyalty program, provides exclusive access to promotions, product drops and content. store pickup. MedMen Buds, an industry?first

Events 52

Events Retail Business Dispensary 52

CannaTech

OCTOBER 14, 2018

The state was well-positioned to permit this type of farming back in 2013 when Senate Bill 566 was enacted, conditionally approving an industrial hemp pilot program. billion by 2022, according to New Frontier Data, a premier cannabis data analytics firm. In the U.S.

Hemp 53

Hemp Research and Development Agriculture Seed-To-Sale 53

Cannabis Law Report

AUGUST 6, 2021

Adjusted EBITDA loss in Q1 2022 was $64 million , a $29 million narrower loss versus Q1 2021 driven by higher sales and lower operating expenses. Adjusted EBITDA loss in Q1 2022 was negatively impacted by a $10.1 First Quarter Fiscal 2022 Financial Summary. (in Highlights. in millions of Canadian. dollars, unaudited).

Vaping 105

Vaping Research and Development Data Business 105

Project CBD

JUNE 20, 2023

One gastrointestinal condition long associated with self-medication through cannabis is inflammatory bowel disease (IBD). IBD in Puerto Rico In 2016, the government of Puerto Rico legalized medicinal cannabis for a relatively short list of specific conditions, including Crohn’s disease. 239,5 (2022): 1509-1519.

Cannabinoids 208

Cannabinoids Patients Treatment Conditions 208

Cannabis Law Report

AUGUST 4, 2021

We thus provide comparison with the pre-pandemic period of H1 2019 as an additional data point. At the time of FY 2020 results publication, we estimated that EUR 250m revenues had been lost in FY 2020 due to the impact of COVID-19 lockdowns and travel restrictions and the objective was to recover these revenues by 2022.

Business 105

Business Research and Development Environment Food 105

Cannabis Law Report

DECEMBER 9, 2021

million in cash debt owed by Pineapple Express and the issuance of up to approximately 1,126,761 common shares of Fire & Flower, (subject to adjustment in accordance with the terms of the Acquisition, subject to Pineapple Express achieving certain performance-based milestones in the fiscal 2022 year). About Fire & Flower.

Retail 52

Retail Media Collective Conditions 52

Cannabis Law Report

FEBRUARY 2, 2022

A material change report is not expected to be filed by the Company 21 days before the issuance of the Top-up Warrants as the details of the Amendments were only agreed as of February 1, 2022. In the view of the Company, this was reasonable in the circumstances because the Term Loans were due to mature on January 31, 2022.

Events 52

Events Business Retail Conditions 52

Cannabis Law Report

NOVEMBER 12, 2021

(Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance addiction, today announced financial results for the first quarter of its fiscal year ending June 30, 2022 and reported recent business highlights. Condensed Balance Sheet Data. . .

Pharmaceutical 52

Pharmaceutical Clinical Trials Business Research and Development 52

Cannabis Law Report

JANUARY 20, 2022

ELE-Psilo program expected to enter clinical trials in Q2 2022 and to target the pressing need for rapid-acting antidepressants compatible with existing healthcare infrastructure and insurance. Eleusis secured an Innovation Passport Designation for ELE-Psilo in adult treatment-resistant depression under the U.K.

Therapy 52

Therapy Research and Development Business Access 52

The Cannigma

AUGUST 5, 2022

A 2022 study of 22 patients with treatment-resistant depression found a 42% reduction in depressive symptoms with ketamine infusions. Most existing research does not support the use of THC in combating depression and there is very limited data for other cannabinoids.” But this program offers more than just the ketamine itself.

Treatment 138

Treatment Research and Development Therapy Digestion 138

Cannabis Law Report

NOVEMBER 9, 2021

Q1 2022 Highlights. LOS ANGELES–(BUSINESS WIRE)–MedMen Enterprises Inc. (“ MedMen ” or the “ Company ”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis retailer with operations across the United States, today released its consolidated financial results for its first fiscal quarter of 2022, ended September 25, 2021.

Retail 52

Retail Events Cultivation Business 52

Veriheal

SEPTEMBER 14, 2021

While the pool of study subjects could have been larger, researchers were satisfied with the data they gathered from 3,119 respondents. All respondents identified as American military veterans, and the information was pulled from a 2012–2013 National Epidemiologic Survey on Alcohol and Related Conditions–III (NESARC-III). .

Consumption 97

Consumption Research and Development Treatment Programs 97